Alain Maiore is the founder of Mnemo Therapeutics. Mnemo Therapeutics has raised $90M in total funding. Latest round: Series A. Based in Paris, France.
Alain Maiore is the founder and former CEO of Mnemo Therapeutics, a French biotechnology company developing cell therapies for solid and blood cancers. He co-founded the company with Institut Curie and Memorial Sloan Kettering Cancer Center, raising €75 million ($90 million) in Series A funding in June 2021. Maiore departed Mnemo Therapeutics after five years, with his last day there in 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library